적응 방사선 치료 소프트웨어 시장 보고서(2026년)
Adaptive Radiotherapy Software Global Market Report 2026
상품코드 : 1939193
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,691,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,672,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,652,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

적응 방사선 치료 소프트웨어 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 7억 달러에서 2026년에는 8억 1,000만 달러로, CAGR 14.3%로 성장이 전망되고 있습니다. 지난 수년간의 성장세는 영상유도 방사선 치료의 도입 확대, 전 세계 암 발생률 증가, 방사선 종양학 소프트웨어의 발전, 치료 정확도 향상에 대한 수요, 방사선 치료 센터의 확대 등이 주요 요인으로 꼽힙니다.

적응 방사선 치료 소프트웨어 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 14.0%의 CAGR로 13억 6,000만 달러에 달할 전망입니다. 예측 기간 중 성장 요인으로는 개인 맞춤형 암 치료 수요 증가, AI 기반 치료 적응증 통합, 클라우드 기반 종양학 소프트웨어 도입 증가, 방사선 독성 감소에 대한 집중 강화, 첨단 종양학 인프라에 대한 투자 등을 꼽을 수 있습니다. 예측 기간의 주요 동향에는 적응 치료 계획, 영상 유도 선량 최적화, 개인 맞춤형 방사선 치료 프로토콜, 방사선 종양학에서의 워크플로우 자동화, 다중 영상 통합 등이 포함됩니다.

암 발병률 증가는 향후 수년간 적응형 방사선 치료 소프트웨어 시장의 성장을 가속할 것으로 예측됩니다. 암 발생 건수는 특정 기간 중 특정 집단 내에서 암 진단을 받은 개인의 수를 나타냅니다. 수명의 연장으로 유전적 변이가 축적되어 발병 위험이 높아짐에 따라 고령화 사회에서 암 발생률은 증가하는 추세입니다. 적응형 방사선 치료 소프트웨어는 종양의 크기와 모양, 환자의 해부학적 구조 변화에 따라 방사선 치료를 실시간으로 조정하여 치료 정확도를 높이고, 종양 표적을 최적화하며, 정상 조직에 대한 손상을 줄여 암 치료를 돕습니다. 예를 들어 2025년 2월 호주 정부 기관인 Cancer Australia가 발표한 자료에 따르면 2024년 새로 진단받은 췌장암 환자 수는 4,641명(남성 2,414명, 여성 2,227명)이었습니다. 이처럼 암 환자 증가 추세가 적응형 방사선 치료 소프트웨어 시장의 성장을 촉진하고 있습니다.

적응형 방사선 치료 소프트웨어 시장의 주요 기업은 인공지능을 탑재한 적응형 CT-Linac 시스템 등 기술 혁신에 집중하여 실시간 종양 표적화, 치료 정확도, 환자 치료 결과를 향상시키고자 노력하고 있습니다. 인공지능 탑재 적응형 CT-Linac은 컴퓨터단층촬영(CT) 영상과 선형 가속기(리낵)를 결합한 방사선 치료 시스템으로, 인공지능을 활용하여 치료 중 종양의 변화 특성에 따라 방사선 조사량을 적응적으로 조정합니다. 예를 들어 2024년 5월 스웨덴에 본사를 둔 제약 및 의료 기술 기업 Elektar AB는 정확하고 효율적인 방사선 치료를 제공하는 시스템인 'Evo'를 발표했습니다. Evo는 인공지능으로 강화된 첨단 영상 진단 기능을 제공하여 개인 맞춤형 암 방사선 치료를 실현합니다. 이를 통해 임상의는 종양에 대한 명확한 가시성을 확보하고, 치료 세션 중 또는 세션 간 치료 조정을 할 수 있습니다. 이 기술은 정확도 향상, 부작용 감소, 환자의 삶의 질 향상을 목표로 하는 동시에 의료 기관이 자신의 운영 속도에 맞추어 이러한 진보를 도입할 수 있는 유연성을 제공합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Adaptive radiotherapy software is a specialized tool in radiation oncology that allows real-time or near-real-time adjustments to radiotherapy treatment plans based on changes in a patient's anatomy, tumor size, or position during treatment. It combines imaging data, including CT, MRI, or cone-beam CT, with treatment planning systems to optimize radiation delivery, enhance tumor targeting, and reduce exposure to surrounding healthy tissues.

The primary component types of adaptive radiotherapy software are software and services. Software includes adaptive radiotherapy programs and platforms used for planning, monitoring, and delivering precise radiation treatments. These solutions are deployed through on-premises and cloud-based platforms. Applications include prostate cancer, head and neck cancer, breast cancer, lung cancer, and other conditions. End-users include hospitals, cancer treatment centers, research institutes, and related healthcare facilities.

Tariffs have influenced the adaptive radiotherapy software market by increasing costs for imported software components, imaging integration tools, and IT infrastructure used in advanced radiotherapy systems. Higher tariffs have particularly impacted hospitals and cancer treatment centers in developing regions that rely on imported oncology software solutions, especially across Asia-Pacific and Latin America. These cost pressures have slowed software upgrades and new installations in price-sensitive markets. However, tariffs have also encouraged regional software development, local partnerships, and cloud-based deployment models, supporting long-term market resilience and innovation.

The adaptive radiotherapy software market research report is one of a series of new reports from The Business Research Company that provides adaptive radiotherapy software market statistics, including adaptive radiotherapy software industry global market size, regional shares, competitors with a adaptive radiotherapy software market share, detailed adaptive radiotherapy software market segments, market trends and opportunities, and any further data you may need to thrive in the adaptive radiotherapy software industry. This adaptive radiotherapy software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adaptive radiotherapy software market size has grown rapidly in recent years. It will grow from $0.7 billion in 2025 to $0.81 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing adoption of image-guided radiotherapy, rising cancer incidence globally, advancements in radiation oncology software, demand for improved treatment accuracy, expansion of radiotherapy centers.

The adaptive radiotherapy software market size is expected to see rapid growth in the next few years. It will grow to $1.36 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, integration of AI-driven treatment adaptation, rising adoption of cloud-based oncology software, increasing focus on reducing radiation toxicity, investments in advanced oncology infrastructure. Major trends in the forecast period include adaptive treatment planning, image-guided dose optimization, personalized radiation therapy protocols, workflow automation in radiation oncology, multi-modality imaging integration.

The increasing prevalence of cancer is expected to drive the expansion of the adaptive radiotherapy software market in the coming years. Cancer cases indicate the number of individuals diagnosed with cancer within a specific population over a defined timeframe. The incidence of cancer is growing among aging populations, as longer lifespans lead to a greater accumulation of genetic mutations, which raises the likelihood of developing the disease. Adaptive radiotherapy software aids cancer treatment by modifying radiation therapy in real time according to changes in tumor size, shape, and patient anatomy, enhancing precision, optimizing tumor targeting, and reducing harm to healthy tissues. For example, in February 2025, Cancer Australia, an Australian government agency, reported 4,641 new cases of pancreatic cancer in 2024, including 2,414 males and 2,227 females. Thus, the rising prevalence of cancer is fueling the growth of the adaptive radiotherapy software market.

Leading companies in the adaptive radiotherapy software market are focusing on technological innovations such as artificial intelligence-powered adaptive CT-Linac systems to improve real-time tumor targeting, treatment precision, and patient outcomes. An artificial intelligence-powered adaptive CT-Linac is a radiation therapy system that combines computed tomography imaging with a linear accelerator, utilizing artificial intelligence to adapt radiation delivery during treatment based on the tumor's evolving characteristics. For example, in May 2024, Elekta AB, a pharmaceutical and medical technology company based in Sweden, introduced Evo, a system designed to provide highly accurate and efficient radiotherapy. Evo delivers personalized cancer radiation treatment by offering advanced imaging capabilities enhanced by artificial intelligence, allowing clinicians to clearly visualize tumors and make treatment adjustments either during or between sessions. This technology aims to improve accuracy, reduce adverse effects, and enhance patient quality of life, while offering clinics the flexibility to implement these advancements at a pace that suits their operations.

In April 2024, GE Healthcare Technologies Inc., a medical diagnostics company based in the United States, acquired MIM Software Inc. for an undisclosed amount. This acquisition is intended to support GE Healthcare's precision care strategy by incorporating MIM Software's artificial intelligence-powered imaging analysis and digital workflow tools, thereby improving the delivery of precise, coordinated, and efficient care across various disease areas. MIM Software Inc. is a United States-based software company that specializes in adaptive radiotherapy solutions.

Major companies operating in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brainlab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.

North America was the largest region in the adaptive radiotherapy software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adaptive radiotherapy software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adaptive radiotherapy software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adaptive radiotherapy software market consists of revenues earned by entities by providing services such as imaging data processing services, radiation dose adjustment services, real-time monitoring services, clinical workflow customization services, and regulatory compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The adaptive radiotherapy software market also includes sales of imaging systems, treatment planning systems, verification tools, deformable registration tools, oncology information systems, and dose tracking systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adaptive Radiotherapy Software Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses adaptive radiotherapy software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for adaptive radiotherapy software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adaptive radiotherapy software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Adaptive Radiotherapy Software Market Characteristics

3. Adaptive Radiotherapy Software Market Supply Chain Analysis

4. Global Adaptive Radiotherapy Software Market Trends And Strategies

5. Adaptive Radiotherapy Software Market Analysis Of End Use Industries

6. Adaptive Radiotherapy Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Adaptive Radiotherapy Software Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Adaptive Radiotherapy Software Total Addressable Market (TAM) Analysis for the Market

9. Adaptive Radiotherapy Software Market Segmentation

10. Adaptive Radiotherapy Software Market Regional And Country Analysis

11. Asia-Pacific Adaptive Radiotherapy Software Market

12. China Adaptive Radiotherapy Software Market

13. India Adaptive Radiotherapy Software Market

14. Japan Adaptive Radiotherapy Software Market

15. Australia Adaptive Radiotherapy Software Market

16. Indonesia Adaptive Radiotherapy Software Market

17. South Korea Adaptive Radiotherapy Software Market

18. Taiwan Adaptive Radiotherapy Software Market

19. South East Asia Adaptive Radiotherapy Software Market

20. Western Europe Adaptive Radiotherapy Software Market

21. UK Adaptive Radiotherapy Software Market

22. Germany Adaptive Radiotherapy Software Market

23. France Adaptive Radiotherapy Software Market

24. Italy Adaptive Radiotherapy Software Market

25. Spain Adaptive Radiotherapy Software Market

26. Eastern Europe Adaptive Radiotherapy Software Market

27. Russia Adaptive Radiotherapy Software Market

28. North America Adaptive Radiotherapy Software Market

29. USA Adaptive Radiotherapy Software Market

30. Canada Adaptive Radiotherapy Software Market

31. South America Adaptive Radiotherapy Software Market

32. Brazil Adaptive Radiotherapy Software Market

33. Middle East Adaptive Radiotherapy Software Market

34. Africa Adaptive Radiotherapy Software Market

35. Adaptive Radiotherapy Software Market Regulatory and Investment Landscape

36. Adaptive Radiotherapy Software Market Competitive Landscape And Company Profiles

37. Adaptive Radiotherapy Software Market Other Major And Innovative Companies

38. Global Adaptive Radiotherapy Software Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Adaptive Radiotherapy Software Market

40. Adaptive Radiotherapy Software Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기